Esperion Therapeutics climbs as company says high cholesterol drug met goals in trial
October 01, 2014 at 17:46 PM EDT
Shares of Esperion Therapeutics surged in aftermarket trading Wednesday after the company reported positive clinical trial results for its experimental high-cholesterol drug ETC-1002.
